HEADER TRANSCRIPTION 17-NOV-15 5ETH TITLE RORY IN COMPLEX WITH INVERSE AGONIST 3. COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN (UNP RESIDUES 267-487); COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX KEYWDS ROR GAMMA, INVERSE AGONIST, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR D.M.MARCOTTE REVDAT 3 27-SEP-23 5ETH 1 JRNL REMARK REVDAT 2 29-JUN-16 5ETH 1 JRNL REVDAT 1 27-APR-16 5ETH 0 JRNL AUTH I.J.ENYEDY,N.A.POWELL,J.CARAVELLA,K.VAN VLOTEN,J.CHAO, JRNL AUTH 2 D.BANERJEE,D.MARCOTTE,L.SILVIAN,A.MCKENZIE,V.S.HONG, JRNL AUTH 3 J.D.FONTENOT JRNL TITL DISCOVERY OF BIARYLS AS ROR GAMMA INVERSE AGONISTS BY USING JRNL TITL 2 STRUCTURE-BASED DESIGN. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 2459 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 27080181 JRNL DOI 10.1016/J.BMCL.2016.03.109 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0131 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 9761 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1168 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.88 REMARK 3 REFLECTION IN BIN (WORKING SET) : 633 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.3270 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3452 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37000 REMARK 3 B22 (A**2) : 0.34000 REMARK 3 B33 (A**2) : 0.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.504 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.427 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 22.697 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.842 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3628 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3391 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4919 ; 1.595 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7746 ; 3.218 ; 3.009 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 443 ; 4.994 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 165 ;35.510 ;23.576 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 615 ;17.947 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;16.371 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 541 ; 0.113 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4094 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 888 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1768 ; 2.377 ; 4.542 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1765 ; 2.370 ; 4.538 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2210 ; 3.852 ; 6.818 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5ETH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215493. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10930 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.803 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.47900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4ZOM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21% PEG3350, 0.2M AMMONIUM ACETATE, REMARK 280 0.1M BISTRIS PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 62.77950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.20650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 62.77950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.20650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 607 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 265 REMARK 465 PRO A 266 REMARK 465 LEU A 267 REMARK 465 THR A 268 REMARK 465 GLN A 487 REMARK 465 GLY B 265 REMARK 465 PRO B 266 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 282 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 288 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 294 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 ARG A 374 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 437 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 440 CG CD OE1 OE2 REMARK 470 GLN A 441 CG CD OE1 NE2 REMARK 470 LYS A 469 CG CD CE NZ REMARK 470 GLN A 478 CG CD OE1 NE2 REMARK 470 LEU B 267 CG CD1 CD2 REMARK 470 GLU B 269 CG CD OE1 OE2 REMARK 470 GLN B 275 CG CD OE1 NE2 REMARK 470 ARG B 288 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 290 CG CD OE1 OE2 REMARK 470 ARG B 294 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 302 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 303 CG CD OE1 OE2 REMARK 470 ARG B 310 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 315 CG CD OE1 OE2 REMARK 470 ASN B 347 CG OD1 ND2 REMARK 470 GLU B 386 CG CD OE1 OE2 REMARK 470 GLU B 395 CG CD OE1 OE2 REMARK 470 LYS B 436 CG CD CE NZ REMARK 470 ARG B 437 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 469 CG CD CE NZ REMARK 470 LYS B 471 CG CD CE NZ REMARK 470 ARG B 473 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 478 CG CD OE1 NE2 REMARK 470 ARG B 482 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 367 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -61.51 75.23 REMARK 500 SER A 477 -159.99 -138.24 REMARK 500 ILE B 485 -8.81 -59.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER B 477 GLN B 478 -122.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5RT A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5RT B 501 DBREF 5ETH A 267 487 UNP P51449 RORG_HUMAN 267 487 DBREF 5ETH B 267 487 UNP P51449 RORG_HUMAN 267 487 SEQADV 5ETH GLY A 265 UNP P51449 EXPRESSION TAG SEQADV 5ETH PRO A 266 UNP P51449 EXPRESSION TAG SEQADV 5ETH GLY B 265 UNP P51449 EXPRESSION TAG SEQADV 5ETH PRO B 266 UNP P51449 EXPRESSION TAG SEQRES 1 A 223 GLY PRO LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL SEQRES 2 A 223 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU SEQRES 3 A 223 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU SEQRES 4 A 223 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET SEQRES 5 A 223 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN SEQRES 6 A 223 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET SEQRES 7 A 223 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA SEQRES 8 A 223 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA SEQRES 9 A 223 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS SEQRES 10 A 223 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER SEQRES 11 A 223 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU SEQRES 12 A 223 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR SEQRES 13 A 223 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU SEQRES 14 A 223 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU SEQRES 15 A 223 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG SEQRES 16 A 223 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU SEQRES 17 A 223 ARG SER LEU CYS SER GLN HIS VAL GLU ARG LEU GLN ILE SEQRES 18 A 223 PHE GLN SEQRES 1 B 223 GLY PRO LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL SEQRES 2 B 223 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU SEQRES 3 B 223 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU SEQRES 4 B 223 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET SEQRES 5 B 223 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN SEQRES 6 B 223 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET SEQRES 7 B 223 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA SEQRES 8 B 223 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA SEQRES 9 B 223 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS SEQRES 10 B 223 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER SEQRES 11 B 223 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU SEQRES 12 B 223 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR SEQRES 13 B 223 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU SEQRES 14 B 223 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU SEQRES 15 B 223 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG SEQRES 16 B 223 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU SEQRES 17 B 223 ARG SER LEU CYS SER GLN HIS VAL GLU ARG LEU GLN ILE SEQRES 18 B 223 PHE GLN HET 5RT A 501 36 HET 5RT B 501 36 HETNAM 5RT 1-METHYL-~{N}-(1-THIOPHEN-2-YLCARBONYL-3,4-DIHYDRO- HETNAM 2 5RT 2~{H}-QUINOLIN-6-YL)-~{N}-[2,2,2-TRIS(FLUORANYL) HETNAM 3 5RT ETHYL]INDOLE-4-SULFONAMIDE FORMUL 3 5RT 2(C25 H22 F3 N3 O3 S2) FORMUL 5 HOH *22(H2 O) HELIX 1 AA1 GLU A 269 CYS A 285 1 17 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 LYS A 311 1 11 HELIX 5 AA5 SER A 312 LEU A 338 1 27 HELIX 6 AA6 GLY A 340 LEU A 344 5 5 HELIX 7 AA7 CYS A 345 MET A 365 1 21 HELIX 8 AA8 GLY A 384 GLY A 392 5 9 HELIX 9 AA9 CYS A 393 ALA A 409 1 17 HELIX 10 AB1 SER A 413 ILE A 426 1 14 HELIX 11 AB2 GLU A 435 THR A 457 1 23 HELIX 12 AB3 ARG A 459 LEU A 466 5 8 HELIX 13 AB4 PRO A 468 CYS A 476 1 9 HELIX 14 AB5 SER A 477 GLU A 481 5 5 HELIX 15 AB6 ARG A 482 PHE A 486 5 5 HELIX 16 AB7 THR B 268 CYS B 285 1 18 HELIX 17 AB8 ARG B 288 GLN B 295 1 8 HELIX 18 AB9 ARG B 296 ASN B 298 5 3 HELIX 19 AC1 SER B 301 LYS B 311 1 11 HELIX 20 AC2 SER B 312 LEU B 338 1 27 HELIX 21 AC3 GLY B 340 LEU B 344 5 5 HELIX 22 AC4 CYS B 345 MET B 365 1 21 HELIX 23 AC5 GLY B 384 GLY B 392 5 9 HELIX 24 AC6 CYS B 393 ALA B 409 1 17 HELIX 25 AC7 SER B 413 ILE B 426 1 14 HELIX 26 AC8 GLU B 435 THR B 457 1 23 HELIX 27 AC9 ARG B 459 LEU B 466 5 8 HELIX 28 AD1 PRO B 468 CYS B 476 1 9 HELIX 29 AD2 SER B 477 GLU B 481 5 5 HELIX 30 AD3 ARG B 482 GLN B 487 5 6 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 SITE 1 AC1 13 CYS A 320 HIS A 323 LEU A 324 ALA A 327 SITE 2 AC1 13 MET A 358 VAL A 361 MET A 365 VAL A 376 SITE 3 AC1 13 PHE A 378 PHE A 388 ILE A 400 PHE A 401 SITE 4 AC1 13 VAL A 480 SITE 1 AC2 14 TRP B 317 CYS B 320 HIS B 323 LEU B 324 SITE 2 AC2 14 ALA B 327 VAL B 361 MET B 365 PHE B 378 SITE 3 AC2 14 PHE B 388 LEU B 396 ILE B 400 PHE B 401 SITE 4 AC2 14 CYS B 476 VAL B 480 CRYST1 125.559 56.413 77.922 90.00 124.67 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007964 0.000000 0.005509 0.00000 SCALE2 0.000000 0.017726 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015604 0.00000